EcoR1 Capital, LLC Quant / Systematic

CIK: 0001587114 · Show all filings

Period: Q2 2019 (← Previous) (Next →)

Filing Date: Aug 14, 2019

Total Value ($000): $989,642 (100.0% shares, 0.0% debt)

Holdings (39)

KURA KURA ONCOLOGY ORD 10.5%
Value ($000) $103,899 Shares 5,276,753 Est. Cost $10.87 Unrealized +52.7%
XNCR XENCOR ORD 9.7%
Value ($000) $95,635 Shares 2,336,557 Est. Cost $34.67 Unrealized -5.2%
ARGX ARGENX ADR REP ORD 8.3%
Value ($000) $82,281 Shares 581,165 Est. Cost $96.07 Unrealized
CRSP CRISPR THERAPEUTICS ORD 7.7%
Value ($000) $75,843 Shares 1,610,250 Est. Cost $36.55 Unrealized +9.3%
FIBROGEN ORD 6.9%
Value ($000) $68,302 Shares 1,511,785 Est. Cost $44.16 Unrealized
SPARK THERAPEUTICS ORD 6.4%
Value ($000) $62,874 Shares 614,128 Est. Cost $57.68 Unrealized
MIRATI THERAPEUTICS ORD 6.2%
Value ($000) $61,564 Shares 597,711 Est. Cost $53.32 Unrealized
DICERNA PHARMACEUTICALS ORD 5.3%
Value ($000) $52,233 Shares 3,316,407 Est. Cost $9.60 Unrealized
IRWD IRONWOOD PHARMA CL A ORD 5.2%
Value ($000) $51,105 Shares 4,671,408 Est. Cost $11.82 Unrealized -5.2%
MORPHIC HOLDING ORD 4.5%
Value ($000) $44,928 Shares 2,266,804 Est. Cost $19.82 Unrealized
RARE ULTRAGENYX PHARMACEUTICAL ORD 3.2%
Value ($000) $31,617 Shares 497,899 Est. Cost $57.14 Unrealized +11.4%
PREVAIL THERAPEUTICS ORD 3.2%
Value ($000) $31,582 Shares 2,392,556 Est. Cost $13.20 Unrealized
ATRECA CL A ORD 2.8%
Value ($000) $28,015 Shares 1,486,979 Est. Cost $18.84 Unrealized
CHIASMA ORD 2.3%
Value ($000) $22,737 Shares 3,043,827 Est. Cost $5.00 Unrealized
HARPOON THERAPEUTICS ORD 1.8%
Value ($000) $17,529 Shares 1,348,423 Est. Cost $9.47 Unrealized
GOSS GOSSAMER BIO INC ORD 1.7%
Value ($000) $17,125 Shares 772,096 Est. Cost $20.85 Unrealized -8.3%
ARQULE ORD 1.4%
Value ($000) $14,313 Shares 1,300,000 Est. Cost $11.01 Unrealized
FIBROGEN ORD 1.3%
Value ($000) $12,537 Shares 277,500 Est. Cost $44.16 Unrealized
EIGER BIOPHARMACEUTICAL ORD 1.2%
Value ($000) $12,042 Shares 1,136,043 Est. Cost $11.49 Unrealized
RCUS ARCUS BIOSCIENCES ORD 1.2%
Value ($000) $11,787 Shares 1,488,205 Est. Cost $14.43 Unrealized -30.6%
UNITY BIOTECHNOLOGY ORD 1.0%
Value ($000) $9,923 Shares 1,044,500 Est. Cost $14.33 Unrealized
CYCLERION THERAPEUTICS ORD 0.9%
Value ($000) $8,888 Shares 776,206 Est. Cost $11.45 Unrealized
PRTA PROTHENA ORD 0.8%
Value ($000) $7,645 Shares 723,300 Est. Cost $11.89 Unrealized -13.6%
RUBIUS THERAPEUTICS ORD 0.7%
Value ($000) $7,285 Shares 463,152 Est. Cost $23.51 Unrealized
ASSEMBLY BIOSCIENCES ORD 0.7%
Value ($000) $6,723 Shares 498,300 Est. Cost $8.38 Unrealized
SURFACE ONCOLOGY ORD 0.7%
Value ($000) $6,522 Shares 2,312,688 Est. Cost $10.23 Unrealized
MERSANA THERAPEUTICS ORD 0.6%
Value ($000) $5,639 Shares 1,392,231 Est. Cost $5.26 Unrealized
CURIS ORD 0.6%
Value ($000) $5,547 Shares 2,982,208 Est. Cost $0.69 Unrealized
AQUINOX PHARMACEUTICALS ORD 0.5%
Value ($000) $5,347 Shares 2,265,880 Est. Cost $2.79 Unrealized
RYTM RHYTHM PHARMACEUTICALS ORD 0.5%
Value ($000) $4,910 Shares 223,167 Est. Cost $27.64 Unrealized -8.6%
SOLID BIOSCIENCES ORD 0.5%
Value ($000) $4,755 Shares 827,000 Est. Cost $5.75 Unrealized
NGM BIOPHARMACEUTICALS ORD 0.5%
Value ($000) $4,639 Shares 316,900 Est. Cost $14.64 Unrealized
KEZAR LIFE SCIENCES ORD 0.5%
Value ($000) $4,497 Shares 583,293 Est. Cost $17.35 Unrealized
ADURO BIOTECH ORD 0.3%
Value ($000) $2,713 Shares 1,761,421 Est. Cost $3.98 Unrealized
VCEL VERICEL ORD 0.3%
Value ($000) $2,475 Shares 131,001 Est. Cost $18.29 Unrealized -6.8%
SYROS PHARMACEUTICALS ORD 0.2%
Value ($000) $2,301 Shares 248,480 Est. Cost $9.26 Unrealized
REGULUS THERAPEUTICS 0.1%
Value ($000) $1,389 Shares 1,111,110 Est. Cost $1.25 Unrealized
GAMIDA CELL ORD 0.0%
Value ($000) $265 Shares 52,120 Est. Cost $5.08 Unrealized
TCR2 THERAPEUTICS ORD 0.0%
Value ($000) $231 Shares 16,114 Est. Cost $14.34 Unrealized